Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM4 | Q14833 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16881654 | 0.84 | HTR2C (0.35) | HTR2CLMNAHSD17B10ADRA2AADRA1A | |
| SCHEMBL19787823 | 0.81 | HTR2C (0.33) | HTR2CLMNAHSD17B10ADRA2AADRA1A | |
| SCHEMBL19387343 | 0.79 | HTR2C (0.36) | HTR2CLMNAHSD17B10 | |
| SCHEMBL13299282 | 0.79 | DGKA (0.44) | GRM4HTR2CLMNAHSD17B10ADRA2A | |
| SCHEMBL18823278 | 0.77 | HTR2C (0.41) | HTR2CLMNAHSD17B10ADRA2AADRA1A | |
| SCHEMBL23408786 | 0.76 | HTR2C (0.34) | HTR2CLMNAHSD17B10 | |
| SCHEMBL21742551 | 0.76 | GRM4 (0.37) | GRM4LMNAHSD17B10 | |
| SCHEMBL3121478 | 0.75 | GLRA1 (0.39) | HTR2CLMNAHSD17B10ADRA2AADRA1A | |
| SCHEMBL28817815 | 0.75 | HTR2C (0.43) | HTR2CHTR1ACYP2C19 | |
| SCHEMBL18274698 | 0.75 | MEN1 (0.52) | HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2099423-B1 | METHOD OF HAIR TREATMENT | UNILEVER PLC (GB) | 2011-03-30 | — | — | EP | disclosed |
| US-20100291017-A1 | Hair Treatment Compositions | CONOPCO, INC. D/B/A UNILEVER | 2010-11-18 | — | — | US | disclosed |
| EP-2097468-B1 | COMPOSITION COMPRISING BRUSH COPOLYMER FOR TREATING HAIR | UNILEVER PLC (GB) | 2010-08-25 | — | — | EP | disclosed |
| EP-1959918-B1 | HAIR TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2010-06-30 | — | — | EP | disclosed |
| EP-1737420-B1 | HAIR TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2010-06-02 | — | — | EP | disclosed |
| US-20080286220-A1 | Hair Treatment Compositions Comprising A Disaccharide, A Di-Acid And A Source Of Ammonium Ions | CONOPCO, INC. D/B/A UNILEVER | 2008-11-20 | — | — | US | disclosed |
| EP-1732506-B1 | HAIR TREATMENT COMPOSITIONS COMPRISING A DISACCHARIDE, A DI-ACID AND A SOURCE OF AMMONIUM IONS | UNILEVER PLC (GB) | 2008-09-10 | — | — | EP | disclosed |
| US-20080193401-A1 | Hair Treatment Composition | CONOPCO, INC. D/B/A UNILEVER | 2008-08-14 | — | — | US | disclosed |
| EP-1569602-B1 | HAIR TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2007-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100291017-A1 | Hair Treatment Compositions | OAT, NACA, BCAT2 | GRM4 1232/4885HTR2C 487/4885LMNA 4071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.